O020 Asthma exacerbations and lung function decline in children during a 52-week controlled trial of omalizumab.

Details

Language :

English

ISSN :

10811206

Volume :

117

Database :

Supplemental Index

Journal :

Annals of Allergy, Asthma & Immunology

Publication Type :

Academic Journal

Accession number :

118998801

Full Text :

https://doi.org/10.1016/j.anai.2016.09.380